Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.

NCT01844115 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT01844115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01844115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Lead sponsor
Forest Laboratories
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2013
Completion date
March 31, 2014
Enrollment
415 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

generalized anxiety disorder